Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Transpl Infect Dis ; 18(1): 98-104, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26460906

ABSTRACT

Norovirus is a major cause of self-limited gastroenteritis worldwide. Prevention and treatment are thwarted by rapid viral evolution, and thus supportive care remains the mainstay of therapy. Chronic infection in immunocompromised hosts is increasingly described. We report a case of norovirus infection lasting 2543 days in a pancreas transplant recipient. Serial fecal specimens were obtained, from which a map of genetic relatedness was derived. The clinical course was complicated by renal failure that progressed to end-stage renal disease. Minimization of immunosuppression was associated with resolution of the infection. Subsequently, the patient experienced a suspected allograft rejection that did not compromise pancreas function. The patient later underwent living-related renal transplantation without recurrence of enteritis.


Subject(s)
Caliciviridae Infections/virology , Gastroenteritis/virology , Kidney Failure, Chronic/complications , Norovirus/isolation & purification , Pancreas Transplantation/adverse effects , Caliciviridae Infections/complications , Chronic Disease , Female , Gastroenteritis/complications , Graft Rejection , Humans , Immunocompromised Host , Immunosuppression Therapy/adverse effects , Middle Aged , Norovirus/genetics
2.
Transpl Infect Dis ; 12(1): 87-93, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19735384

ABSTRACT

Multi-drug resistant (MDR) gram-negative infections among solid organ transplant (SOT) recipients have long been associated with high morbidity and mortality. Acinetobacter baumannii has emerged as a potent nosocomial pathogen with the recent acquisition of resistance to broad-spectrum beta-lactams, aminoglycosides, fluoroquinolones, and most notably, carbapenems. Despite a national rise in carbapenem-resistant A. baumannii (CRAB) infections, outcomes among SOT recipients with this emerging MDR pathogen are largely unknown. This single-center cohort is the first to describe the characteristics, complications, and outcomes among abdominal organ transplant recipients with CRAB. The current study suggests that SOT patients with CRAB suffer from prolonged hospitalization, infection with other MDR organisms, allograft dysfunction and loss, and high overall infection-related mortality.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Organ Transplantation/adverse effects , beta-Lactam Resistance , Acinetobacter Infections/diagnosis , Acinetobacter Infections/mortality , Adult , Aged , Female , Humans , Kidney Transplantation/adverse effects , Liver Transplantation/adverse effects , Male , Middle Aged
4.
Transpl Infect Dis ; 6(2): 77-80, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15522109

ABSTRACT

This report describes the clinical course of a liver transplant recipient in whom cavitary pneumonia developed due to Legionella pneumophila. We review the experience with cavitary pulmonary processes caused by Legionella species in liver allograft recipients and describe the diagnostic microbiology of this organism. The clinical course of this patient demonstrates the importance of considering legionellosis in the differential diagnosis of lung abscesses after liver transplantation and the diagnostic difficulties encountered with this bacterium.


Subject(s)
Legionella pneumophila/isolation & purification , Legionnaires' Disease/microbiology , Liver Transplantation/adverse effects , Lung Abscess/microbiology , Adult , Female , Humans , Legionnaires' Disease/diagnosis , Lung Abscess/diagnosis , Transplantation, Homologous/adverse effects
5.
Arch Intern Med ; 160(18): 2819-22, 2000 Oct 09.
Article in English | MEDLINE | ID: mdl-11025792

ABSTRACT

BACKGROUND: The development of antimicrobial guidelines is one way in which institutions attempt to control emerging resistance, but the real challenge falls on promoting and ensuring adherence to these guidelines. Investigating reasons for the prescribing of alternative antimicrobial agents outside of these guidelines is crucial for modifying practices that may adversely impact institutional antimicrobial goals. METHODS: Retrospective cross-referencing of computerized pharmacy printouts and concurrent manual medical record review. RESULTS: Approximately 25% (470/1893) of the patients requiring antimicrobial therapy reported an allergy to at least 1 antimicrobial agent. The most commonly reported antimicrobial allergy was penicillin (295/1893 [15.6%]). Eighty-five patients (18.1%) reported having an allergy to 2 or more antimicrobial agents. Only 4% (27/601) of the reported antimicrobial allergies contained documentation as to the nature of the specific allergic reactions, while a manual medical record review revealed that 32% (23/73) of the antimicrobial allergies contained documentation of the specific allergic reaction. Ninety-eight (39. 7%) of 247 patients reporting an allergy only to penicillin and/or cephalosporin received vancomycin in comparison with 247 (17.4%) of 1423 patients without any antimicrobial allergies (P<.001). Similarly, 53 (21.5%) of 247 patients with reported penicillin and/or cephalosporin allergies received levofloxacin compared with 114 (8.0%) of 1423 patients without any antimicrobial allergy (P<. 001). CONCLUSION: The incidence of penicillin allergy at our institution exceeds population averages. This finding, in combination with limited documentation of drug allergies, appears to lead to the prescribing of alternative antimicrobial agents that do not fit into institutional antimicrobial guidelines and, in some instances, may put the patient at risk for infection and/or colonization with resistant organisms. Use of these alternative agents may adversely impact the ability to manage emerging antimicrobial resistance.


Subject(s)
Anti-Bacterial Agents/adverse effects , Drug Hypersensitivity/epidemiology , Drug Resistance, Microbial , Hospitalization/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Chicago/epidemiology , Cross-Sectional Studies , Drug Hypersensitivity/etiology , Hospital Records , Humans , Incidence , Practice Guidelines as Topic , Retrospective Studies , Risk Factors
6.
Int J Antimicrob Agents ; 10(2): 95-105, 1998 May.
Article in English | MEDLINE | ID: mdl-9716286

ABSTRACT

As the problem of global antibiotic resistance continues to worsen, aminoglycosides have assumed increasing importance in clinical practice. Their broad antimicrobial spectrum, rapid bactericidal action, and ability to act synergistically with other drugs have made them especially useful in the treatment of serious nosocomial infections. However, as with other drugs, their overuse and misuse leads to the development of resistance in important microbial pathogens. The appropriate use of the aminoglycosides is essential to assure their continued efficacy. Therefore, physicians must familiarize themselves with both the clinical indications and the limitations of these drugs if they are to remain efficacious in the years to come.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Aminoglycosides , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Cross Infection/drug therapy , Drug Antagonism , Drug Resistance, Microbial , Drug Synergism , Drug Therapy, Combination/therapeutic use , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...